EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluating Apparent Diffusion Coefficient (ADC) as a Non-invasive Imaging Biomarker for Breast Cancer Prognosis: Correlation with Histopathological and Molecular Biomarkers

Reza Kouhi, Fariborz Faeghi, Masoumeh Guity, Hossein Jomleh, Ali Shamooshaki

International Journal of Cancer Management · 14.02.2026 · 19 (1)

DOI: 10.5812/ijcm-166882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer Management, online erschienen am 14.02.2026. Verfasst von Reza Kouhi und 4 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study evaluates the potential of apparent diffusion coefficient (ADC) values derived from diffusion-weighted imaging (DWI) as non-invasive imaging biomarkers for breast cancer prognosis, correlating them with key histopathological and molecular features.

Objectives

To assess the diagnostic accuracy of (ADC values derived from diffusion-weighted MRI for predicting breast cancer prognostic factors by examining their correlation with histopathological and molecular markers, including ER/PR status, HER2 expression, Ki-67 index, tumor grade, size, and lymph node metastasis.

Methods

In this prospective study, 35 consecutive patients with histologically confirmed breast cancer were recruited through the private radiology office in Tehran, Iran, between December 2017 and August 2018. All patients underwent breast MRI at Athari Imaging Center, Tehran, using a 1.5 T scanner including diffusion-weighted imaging sequences. Histopathology served as the reference standard for all imaging findings. Apparent diffusion coefficient values were measured from manually selected regions of interest and statistically analyzed for correlations with ER/PR, HER2, Ki-67, tumor grade, size, and lymph node status. No indeterminate or missing data were recorded. Receiver operating characteristic (ROC) curve analysis was used to determine diagnostic performance thresholds, and variability in diagnostic accuracy across biomarkers was assessed through AUC comparison.

Results

Significantly lower ADC values were observed in tumors with lymph node metastasis (P = 0.016), high Ki-67 expression (P = 0.042), and positive ER/PR status (P = 0.031). ROC analysis demonstrated high diagnostic performance of ADC for identifying metastatic lymph nodes (AUC = 0.879), ER/PR-positive tumors (AUC = 0.864), and Ki-67-positive tumors (AUC = 0.837). No significant correlations were found between ADC and HER2 status, tumor grade, or size.

Conclusions

Apparent diffusion coefficient values significantly correlate with key prognostic factors in breast cancer, including hormone receptor status, tumor proliferation, and lymph node involvement. These findings highlight ADC as a promising non-invasive diagnostic biomarker for early risk stratification and treatment planning. Larger multicenter studies are warranted to validate these results and support broader clinical application.

Zitieren

APA

Kouhi, R., Faeghi, F., Guity, M., Jomleh, H., & Shamooshaki, A. (2026). Evaluating Apparent Diffusion Coefficient (ADC) as a Non-invasive Imaging Biomarker for Breast Cancer Prognosis: Correlation with Histopathological and Molecular Biomarkers. International Journal of Cancer Management, 19(1). https://doi.org/10.5812/ijcm-166882

Vancouver

Kouhi R, Faeghi F, Guity M, Jomleh H, Shamooshaki A. Evaluating Apparent Diffusion Coefficient (ADC) as a Non-invasive Imaging Biomarker for Breast Cancer Prognosis: Correlation with Histopathological and Molecular Biomarkers. International Journal of Cancer Management. 2026;19(1). doi:10.5812/ijcm-166882

BibTeX
@article{Kouhi2026,
  author = {Kouhi, Reza and Faeghi, Fariborz and Guity, Masoumeh and Jomleh, Hossein and Shamooshaki, Ali},
  title = {Evaluating Apparent Diffusion Coefficient (ADC) as a Non-invasive Imaging Biomarker for Breast Cancer Prognosis: Correlation with Histopathological and Molecular Biomarkers},
  journal = {International Journal of Cancer Management},
  year = {2026},
  volume = {19},
  number = {1},
  doi = {10.5812/ijcm-166882}
}
Kostenlos starten →